Concerns over a terrorist radionuclide threat have prompted the need for improved methods of removing internally deposited radionuclides. Methods for radionuclide removal include chelation therapy, blocking uptake, and accelerating the clearance of ingested or inhaled radionuclides from the body. Natural receptors, which exist in diverse physicochemical forms, often possess versatile chelation properties due to the presence of multiple functional groups, making them capable of binding dissimilar metal ions via multiple chelation mechanisms. The hypothesis of the proposed research is that the natural chelator chitosan is a safe and effective decorporation agent for a wide range of radionuclides.
The Specific Aims designed to test this hypothesis will provide a comprehensive assessment of decorporation efficacy and toxicity of chitosan materials in vitro and in vivo. The initial Aim will include in vitro studies to evaluate the affinity of chitosan materials for radionuclides under physiological conditions, including chemically modifying chitosan for Cs- 137 binding, in order to identity the most promising candidates for subsequent studies.
The second Aim will evaluate the in vivo toxicity of candidate chitosan derivatives in F344 rats in order to refine the most promising candidates, and the final Aim will evaluate the in vivo decorporation efficacy of candidate chitosan derivatives for exposure to radionuclides in order to develop sufficient pharmacokinetic data to estimate utility in human populations using biokinetic dosimetric models. The primary benefit of this research is the rapid development of non-toxic, naturally effective decorporation agents for a wide range of radionuclides. These agents could be already available on the market, or could be easily modified and produced in large quantities. The non-toxic nature of such agents, along with their current use in the medical and pharmaceutical fields will allow these agents to be safely distributed to the general public for both medical mitigation and prophylactic purposes rapidly in the event of a nuclear emergency. ? ? ?
| Levitskaia, Tatiana G; Morris, James E; Creim, Jeffrey A et al. (2010) Aminothiol receptors for decorporation of intravenously administered (60)Co in the rat. Health Phys 98:53-60 |
| Levitskaia, Tatiana G; Creim, Jeffrey A; Curry, Terry L et al. (2010) Biomaterials for the decorporation of (85)Sr in the rat. Health Phys 99:394-400 |
| Levitskaia, Tatiana G; Creim, Jeffrey A; Curry, Terry L et al. (2009) Investigation of chitosan for decorporation of 60Co in the rat. Health Phys 97:115-24 |
